The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines.

Wright, Peter F; Karron, Ruth A; Belshe, Robert B; Shi, Jian R; Randolph, Valerie B; Collins, Peter L; O'Shea, Alice F; Gruber, William C; Murphy, Brian R

Wright, Peter F; Karron, Ruth A; Belshe, Robert B; Shi, Jian R; Randolph, Valerie B; Collins, Peter L; O'Shea, Alice F; Gruber, William C; Murphy, Brian R.

Affiliation

Wright PF; Vanderbilt University, Nashville, TN, USA. peter.wright@vanderbilt.edu

Vaccine ; 25(42): 7372-8, 2007 Oct 16.

Article in En | MEDLINE | ID: mdl-17868959

Subject(s)

Respiratory Syncytial Virus Infections/prevention & control; Respiratory Syncytial Virus Vaccines/pharmacology; Respiratory Syncytial Virus, Human/immunology; Antibodies, Viral/blood; Case-Control Studies; Humans; Infant; Respiratory Syncytial Virus Infections/immunology; Respiratory Syncytial Virus Vaccines/adverse effects; Respiratory Syncytial Virus Vaccines/immunology; Safety; Vaccines, Attenuated/adverse effects; Vaccines, Attenuated/immunology; Vaccines, Attenuated/pharmacology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Syncytial Virus, Human / Respiratory Syncytial Virus Infections / Respiratory Syncytial Virus Vaccines Type of study: Observational_studies / Risk_factors_studies Limits: Humans / Infant Language: En Journal: Vaccine Year: 2007 Document type: Article Affiliation country: United States Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google